Comment: the impact of methodological approach on cost findings in comparison of epoetin alfa with darbepoetin alfa.
Lefebvre
Patrick
P
Vekeman
Francis
F
Cremieux
Pierre-Yves
PY
D000068256:Darbepoetin alfa; D004305:Dose-Response Relationship, Drug; D016527:Drug Costs; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics*; D006397:Hematinics / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D011994:Recombinant Proteins; D012107:Research Design; D013997:Time Factors
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa